LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio welcomes EU strategy to strengthen biotechnology, biomanufacturing and innovation in agri-food systems

    08/09/2026
    PRESS RELEASE

    Brussels, 8 September 2026 - EuropaBio welcomes the publication of the Commission's new Strategic Approach to Research and Innovation for agriculture and food systems. The strategy sends a strong signal that biotechnology is now recognised as a core enabler of Europe's agri-food future, supporting competitiveness, sustainability, resilience and food security. With references spanning agriculture, food systems, the bioeconomy and health, the strategy reflects a growing recognition of the contribution life sciences can make to addressing Europe's economic and societal challenges.

    The strategy also places welcome emphasis on closing Europe's innovation and scale-up gap. By focusing on startups and scale-ups, pilot and demonstration facilities, technology transfer, biomanufacturing and commercialisation pathways, the Commission acknowledges that Europe must do more to turn scientific excellence into industrial leadership and market-ready solutions.

    EuropaBio particularly welcomes the strategic attention given to advanced fermentation. The recognition of fermentation as a key technology for the bioeconomy, together with plans to support pilot and demonstration-scale bioprocessing infrastructure, is an important step toward strengthening domestic production of critical ingredients such as vitamins, enzymes, amino acids and other fermentation-derived products that contribute to Europe's food security, strategic autonomy and secure supply chains.

    The strategy further acknowledges the importance of science-based innovation governance, including stronger risk assessment methodologies, collaboration with risk assessment authorities and the use of regulatory sandboxes. These elements, together with the delivery of complementary initiatives such as the Biotech Acts, will be essential to ensure that innovative solutions can be developed, scaled and commercialised in Europe while maintaining the highest standards of safety and consumer confidence.

    Dr. Claire Skentelbery, Director General of EuropaBio, said: "The strategy recognises that biotech is core to Europe's agri-food framework. It is explicitly referenced as an enabler through all stages of sustainable food production, and a delivery mechanism for secure supply chains."

    EuropaBio welcomes EU strategy to strengthen biotechnology, biomanufacturing and innovation in agri-food systems


    Download
    Share
    Communications Team

    Communications Team

    Related posts

    01/09/2026

    Marije Laffeber joins EuropaBio as Director of Industrial Biotechnology


    Read more
    09/07/2026

    EuropaBio Position on targeted amendments of Directive 2001/18/EC: Unlocking the potential of genetically modified microbial products in Europe (July 2026)


    Read more
    06/07/2026

    EuropaBio Annual Report 2026


    Read more

    Important links

    • EuropaBio welcomes EU strategy to strengthen biotechnology, biomanufacturing and innovation in agri-food systems
    • Marije Laffeber joins EuropaBio as Director of Industrial Biotechnology

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.